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Plasmodium falciparum malaria remains one of the most serious health problems
globally. Immunization with attenuated parasites elicits multiple cellular effector mech-
anisms capable of eliminating Plasmodium liver stages. However, malaria liver stage
(LS) immunity is complex and the mechanisms effector T cells use to locate the
few infected hepatocytes in the large liver in order to kill the intracellular LS par-
asites remain a mystery to date. Here, we review our current knowledge on the
behavior of CD8 effector T cells in the hepatic microvasculature, in malaria and other
hepatic infections. Taking into account the unique immunological and lymphogenic
properties of the liver, we discuss whether classical granule-mediated cytotoxicity
might eliminate infected hepatocytes via direct cell contact or whether cytokines might
operate without cell–cell contact and kill Plasmodium LSs at a distance. A thorough
understanding of the cellular effector mechanisms that lead to parasite death hence
sterile protection is a prerequisite for the development of a successful malaria vac-
cine to protect the 40% of the world’s population currently at risk of Plasmodium
infection.
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Plasmodium falciparummalaria remains one of the most serious health problems globally and long-
lasting protective malaria vaccine is desperately needed. The ability to interrupt the clinically silent
liver phase of the malaria parasite would prevent an estimated 207 million clinical cases every year,
leading to the death of one young African child almost every minute (WHO, 2013). Vaccination
with attenuated parasites elicits multiple cellular effector mechanisms that lead to Plasmodium
liver stage (LS) elimination. While granule-mediated cytotoxicity requires contact between CD8
effector T cells and infected hepatocytes, cytokine mediated parasite killing could occur without
cell–cell contact. This review aims to put into context the biology of the pre-erythrocytic stages
of Plasmodium, the unique immunological and lymphogenic properties of the liver, and recent
insight into the dynamic behavior of CD8 effector T cells in the hepatic microvasculature to
provide a better understanding of the cellular events involved in the blocking of Plasmodium LS
development.
Abbreviations: APC, antigen-presenting cell; BM, bone marrow; BMT, bone marrow transfer; CSP, circumsporozoite
protein; DC, dendritic cell; GAS, genetically attenuated sporozoites; KC, Kupffer cell; LSEC, liver sinusoidal endothelial
cell; RAS, radiation-attenuated sporozoites; TCR-Tg, T cell receptor transgenic.
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Immunity against Pre-Erythrocytic
Plasmodium Antigens
While T cell priming against sporozoite antigens is thought to
occur in the LNs draining themosquito bite skin site (Chakravarty
et al., 2007), the liver draining LNs are the most likely site of T cell
activation against late-LS and early blood stage antigens. However,
T cell priming may also occur in the liver itself, for example
by direct recognition of infected hepatocytes and or via cross-
presentation by the various non-parenchymal antigen-presenting
cell (APCs) including hepatic dendritic cell (DCs; Jobe et al., 2009;
Crispe, 2011; Bertolino and Bowen, 2015). For an overview on
the induction phase of immunity against pre-erythrocytic Plas-
modium antigens, the reader is referred to recent reviews (Crispe,
2014; Van Braeckel-Budimir andHarty, 2014; Radtke et al., 2015).
Here, we focus on the effector phase of the disease and discuss
how the various cellular effector mechanisms might operate in
the liver, upon first infection of a naïve host leading to disease
versus repeated exposure or vaccination resulting in immunity.
We present this review in the context of the unique immunological
and lymphogenic features of the liver.
The Liver, a Metabolic Organ with Unique
Tolerogenic and Lymphogenic Properties
The liver is known as a lymphatic organ with unique immunologi-
cal properties (Knolle and Limmer, 2001; Sheth and Bankey, 2001;
Bertolino et al., 2002; Mackay, 2002; Racanelli and Rehermann,
2006; Crispe, 2009). Its tolerogenic properties, necessitated by
continuous natural exposure to innocuous food antigens and
commensal microbial products from the gastrointestinal tract, are
now widely recognized (Racanelli and Rehermann, 2006; Crispe,
2009; Jenne and Kubes, 2013). It seems likely, therefore, that by
choosing the liver as the initial site of multiplication, Plasmodium
is able to exploit the tolerogenic properties of the liver (Frevert
et al., 2006; Crispe, 2011; Bertolino and Bowen, 2015). Less appre-
ciated is the generation of lymph in this large metabolic organ.
Plasma flows continuously through the sinusoidal sieve plates
and enters the space of Disse (Figure 1). Once in the perisinu-
soidal space, the lymph travels in a retrograde fashion around the
sinusoids toward the periportal space of Mall (Reid et al., 1992).
Despite more than half of the lymph of the entire body being of
hepatic origin (Henriksen et al., 1984; Magari, 1990; Trutmann
and Sasse, 1994; Ohtani and Ohtani, 2008), the contribution
of lymph formation to liver immunology has been surprisingly
underappreciated to date (reviewed in Frevert and Nacer, 2013).
By influencing cytokine dissemination, the unique hepatic blood-
lymph counterflow principle has important implications for the
effector phase of immunity against Plasmodium LS.
Most non-parenchymal liver cells can function as APCs (Jobe
et al., 2009; Crispe, 2011), inducing either tolerance or enhanced
immune responses amongst liver T cells. The state of immune
tolerance rather than immune activation is the more typical and
frequent condition under the steady state. It prevents liver pathol-
ogy arising from a constant inflow of bacterial and othermicrobes
from the gastrointestinal tract and blood-borne antigens from the
systemic circulation. The state of tolerance observed in the liver
is maintained by the production of anti-inflammatory cytokines,
in particular IL-10 (Knolle et al., 1995), and other modulators
such as PGE2 produced by Kupffer cells (KCs) via ligation of
TLR4. Together with nitric oxide, these mediators down-regulate
antigen uptake by liver sinusoidal endothelial cells (LSECs) and
DCs, which leads to a decreased T cell activation (Roland et al.,
1994; Groux et al., 1996). However, KCs have also been shown to
play a role in fighting infections by producing IL-12 and IL-18 and
upregulatingMHC I and IImolecules as well as the co-stimulatory
molecules CD40 and CD80 needed for activation of T cells to
produce IFN-g (Burgio et al., 1998). It appears therefore that
signals received by KCs propel them either into poor and ineffec-
tive or efficient APC, promoting a reversal of immune tolerance.
Tolerance induction or maintenance is also a particular property
of the LSECs (Berg et al., 2006; Ebrahimkhani et al., 2011) with
their typical fenestrations. Although LSECs express MHC I and
II molecules as well as costimulatory molecules involved in T cell
activation, they produce IL-10 upon TLR4 ligation; the ensuing
down-regulation of IL-12 restricts the IFN-g production by T
cells thus reducing the size of the response (Berg et al., 2006;
Ebrahimkhani et al., 2011). The anatomical location of the LSECs
and KCs in the sinusoidal lumenmakes them excellent scavengers
of a plethora of exogenous antigens and enables them to present
these efficiently in the context of MHC I and II molecules in
vivo (Limmer et al., 2000) for the induction of tolerance. The
tolerizing effects of anti-inflammatory responses of liver APCs is
typically observed in vivo to low levels of LPS. Both human and
rodent LSECs upregulateMHC I and expressMHC IImolecules in
response, for example, to viral and bacterial infections or exposure
of the liver to IFN-g (Steinhoff et al., 1988; Steiniger et al., 1988;
Steinhoff, 1990). Similar to KCs and classical splenic DCs, LSECs
can cross-present hepatocyte-associated antigens to CD8 T cells
(Berg et al., 2006; Ebrahimkhani et al., 2011). In contrast, several
functional populations of DCs, the professional APCs, are located
in the periportal connective tissue of the liver lobule (Sumpter
et al., 2007), and they respond to virus infection by elaborating
type I IFN, which ultimately leads to the induction of a pro-
inflammatory environment in the liver. Apart from the most
abundant plasmacytoidDCs, themouse liver also harborsmyeloid
DCs and conventional CD8a+DCs; thus far, the cCD8a+DCs
have no counterpart in the human liver. Amongst the three liver
DC subsets, the cCD8a+DCs have the highest APC capacity.
The Hepatic Cycle of
Plasmodium—Implications for Antigen
Presentation in the Liver
Following Plasmodium infection, mammalian hosts are exposed
to Plasmodium antigens in multiple ways: (1) sporozoite surface
antigens released from viable migrating parasites, (2) sporozoite
antigens from parasites that degrade or are eliminated by phago-
cytosis before they reach their final destination in the liver, (3)
early or late LS antigens from parasites that fail to complete the
hepatic development cycle, and (4) early or late LS antigens, and
potentially blood stage antigens, left behind in the remains of dead
infected hepatocytes after successful merosome release.
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FIGURE 1 | Immunological implications of the hepatic blood-lymph
countercurrent. (A) The liver generates lymph by filtering blood plasma (small
red arrows) through the sieve plates of the sinusoidal endothelial cells (LSEC)
into the perisinusoidal space of Disse formed by LSECs and hepatocytes. The
lymph (green arrows) flows inside the space of Disse around the perisinusoidal
stellate cells (SC) toward the portal field, while the blood (red arrows) continues
its path in the opposite direction, from the portal venule (PV) to the central
venule (CV). (B) LSECs represent the blood-lymph barrier of the liver: they
express both the vascular marker PECAM-1 (red) and the lymphatic marker
LYVE-1 (green). The two markers are depicted separately for clarity.
It has been widely accepted that responses to pre-erythrocytic
stage antigens are rather low in persons residing in P. falciparum
endemic areas (Doolan and Martinez-Alier, 2006). The current
model suggests amongst others, that the few invading sporozoites
leave inadequate antigen levels or that the sporozoites or the LS
antigens that are invisible to the host undergo incomplete or faulty
antigen processing for presentation to T cells. Consequently,
induction of protective T cell and antibody responses by the
erythrocytic stage antigens is rarely observed in naturally infected
persons. It is also possible that the pre-erythrocytic antigens
themselves induce some regulatory T cells or tolerance, both of
which can dampen potential protective responses (EspinozaMora
Mdel et al., 2014; Wilson et al., 2015). Immunization with P. falci-
parum sporozoites, however, can induce high levels of sporozoite-
neutralizing antibodies (Nardin, 2010) thus emphasizing the rel-
evance of studying the presentation of sporozoite antigens such
as circumsporozoite protein (CSP). Protective immunity requires
CD8 memory T cells and CD4 helper T cell-derived cytokines
such as IFN-g that elicit sporozoite-neutralizing antibodies and
inhibit LS development mainly through upregulation of iNOS
and induction of NO in the infected hepatocytes (Doolan and
Martinez-Alier, 2006; Nardin, 2010; Dups et al., 2014). Clinical
trials conducted during the past decades revealed that synthetic
CSP-derived peptide vaccines induce CD4 and CD8 T cells of
similar fine specificity and function (Calvo-Calle et al., 2006;
Oliveira et al., 2008; Othoro et al., 2009; Nardin, 2010). Another
sporozoite surface antigen, the thrombospondin-related adhesive
protein (TRAP), induces transient cytokine responses under nat-
ural exposure conditions (Moormann et al., 2009) and central
memory T cell responses against TRAP are associated with a
significantly reduced incidence of malaria (Todryk et al., 2008).
These findings support recent vaccination strategies aimed at
inducing durable protective T cell responses against TRAP (Ewer
et al., 2013). Interestingly, it was shown that long-term residents
of hyperendemic areas in Africa, who received protracted daily
anti-malarial prophylactic chloroquine treatment to prevent the
development of blood stage infection, developed a strong antibody
response to sporozoites and LSs, but only aweak response to blood
stages (Marchand and Druilhe, 1990; Gruner et al., 2003). In fact,
sera from the individuals displaying responses to sporozoites and
immunity against LS were used successfully to identify two LS-
specific antigens in P. falciparum (Guerin-Marchand et al., 1987;
Sangani et al., 1990). A similar example of T cell responses to
pre-erythrocytic stage antigens comes from the P. vivax malaria.
A recently published study shows that persons, who are negative
for the Duffy antigen and hence are refractory to P. vivax blood-
stage infection, do develop stronger T cell responses to sporozoite
and LS antigens than Duffy antigen-positive subjects (Wang et al.,
2005). These studies suggest that responses to the pre-erythrocytic
stage antigens, be it those associated with sporozoites or with LS,
are indeed inducible. As suggested by others, the presence of blood
stage infection, which vastly exceeds the antigenic load of the
sporozoites and the LS, may negatively influence the induction
of T and B cell responses. Inhibition of antigen presentation by
Frontiers in Microbiology | www.frontiersin.org May 2015 | Volume 6 | Article 4823
Frevert and Krzych Hepatic effector mechanisms against Plasmodium
blood stage antigens has indeed been amply demonstrated in
human (Urban et al., 2005) and animal (Ocana-Morgner et al.,
2003) Plasmodium infections. In the following, we discuss how
the main liver cell types could be involved in the acquisition and
presentation of different Plasmodium antigens.
Sinusoidal Endothelia
In vitro studies revealed that during parasite invasion and traver-
sal, Plasmodium sporozoites continuously release surface antigens
such as CSP and TRAP as part of gliding motility (Stewart and
Vanderberg, 1988, 1991, 1992; Hügel et al., 1996; Spaccapelo
et al., 1997). In addition, sporozoites can also translocate CSP
into the cytosol of mammalian cells by mere membrane contact
(Hügel et al., 1996; Frevert et al., 1998; Pradel and Frevert, 2001).
The implications for antigen processing and presentation of this
phenomenon, which occurs in the absence of invasion, are dis-
cussed below. Various cell types of the liver are likely exposed
to sporozoite-released antigens. As sporozoites glide extensively
along the sinusoids before infecting hepatocytes (Frevert et al.,
2005), a substantial number of LSECs are likely exposed to
released CSP (Figure 2), which they can present for a recall of
both CD8 and CD4 effector T cells (Knolle and Gerken, 2000;
Crispe, 2011). LSECs have also been established as the primary
cross-presentingAPCs of the liver (Limmer et al., 2005). However,
cross-presentation by LSECs can also lead to CD8 T cell tolerance
(Berg et al., 2006). Thus, while LSECs are candidate APCs, their
actual contribution to protective immunity against Plasmodium
CSP or other sporozoite-associated antigens has not been fully
investigated and remains rather difficult to predict.
Kupffer Cells
The vast majority of sporozoite entry events into the hepatic
parenchyma involve KCs (Baer et al., 2007b; Tavares et al., 2013),
resident macrophages and professional APCs of the liver (Crispe,
2011; Figure 2). Early evidence supporting this notion came
from electron micrographs showing P. berghei sporozoites that
stretch from the sinusoidal lumen through KCs all the way into
hepatocytes (Meis and Verhave, 1988). Subsequently, P. yoelii
sporozoites were shown to recognize KC-specific surface proteo-
glycans (Pradel et al., 2002, 2004) and to pass through KCs on
their way into the hepatocytes (Frevert et al., 2005). The use of
KC-deficient mouse models initially implied an obligatory role of
these hepatic macrophages for liver infection (Baer et al., 2007b).
A more recent in vivo study confirmed the involvement of KCs
in the vast majority of all cell traversal events (Tavares et al.,
2013), but also demonstrated that some intravenously injected
sporozoites use a paracellular pathway for liver infection (Tavares
et al., 2013). Thus, while there is no absolute requirement for
KC passage, most sporozoite traversal events involve KCs, either
directly or indirectly.
Based on the finding that the vast majority of SPECT /  P.
berghei sporozoites were trapped in lasting interactions with KCs,
it was proposed that sporozoites must use cell traversal to avoid
clearance by KC in the liver (Tavares et al., 2013). Of note, once
intracellular, these mutant parasites cannot egress from the KC,
and therefore die. This is in contrast to viable WT Plasmodium
sporozoites, which are not killed by KCs, or other macrophages,
from naïve mice (Pradel and Frevert, 2001; Frevert et al., 2006;
Klotz and Frevert, 2008). Further, the infectious dose for naïve
mice is often less than three intravenously injected P. yoelii sporo-
zoites (Conteh et al., 2010). Thus, sporozoite infection of the liver
is highly efficient, which renders the possibility unlikely that KCs
from naïve mice kill sporozoites in vivo. On the other hand, 10%
of intravenously injectedWT P. berghei sporozoites were reported
to be degraded during KC traversal (Tavares et al., 2013). This
disparity could be due to the different parasite species used for
the two studies. Alternatively, as the viability of isolated sporozoite
preparations varies, some of the P. berghei parasites might have
been already dead when they arrived in the liver resulting in
their clearance by phagocytosis. In general, all available evidence
suggests that viable WT sporozoites survive the interaction with
naïve KCs unharmed.
In a separate study assessing the in vivo responses of KCs to
radiation-attenuated P. berghei sporozoites (Pb-RAS), infectious
sporozoites were shown to down-modulate MHC I and IL-12p40
expression (Steers et al., 2005). However, infectious sporozoite
challenge of mice previously immunized with Pb-RAS has the
opposite effect in that the expression of MHC I, co-stimulatory
molecules, and IL-12 are upregulated. In addition, in vitro assessed
APC function of these KCs was significantly enhanced in relation
toKCs obtained fromnaïvemice, naïvemice exposed to infectious
sporozoites or even mice immunized thrice with Pb-RAS (Steers
et al., 2005). Thus, although the prevailing state of immune-
tolerance in the liver might attract Plasmodium sporozoites to
invade hepatocytes where they remain “incognito” as they expand
in number, induction of an inflammatory milieu by Pb-RAS
reverses the hospitality of the liver to a state of immunologic
conflagration that is needed to eliminate the Plasmodium parasite.
Exposure of mice to doses of IL-12 has a similar, albeit short-
lived effect on Plasmodium LS (Sedegah et al., 1994; Hoffman
et al., 1997). By contrast, Pb-RAS immunization induces last-
ing protection that becomes refractory to multiple challenges.
The reason why KCs respond differentially to RAS versus viable
sporozoites is unknown to date. Immunization with the similarly
protective genetically attenuated sporozoites (GAS, Khan et al.,
2012; Nganou-Makamdop and Sauerwein, 2013) or chemically
attenuated sporozoites (CAS, Purcell et al., 2008) may provide
insight into the response of KCs, or other hepatic APCs, to sporo-
zoite encounters that are required for protection. Further, careful
monitoring of location and fate of the various attenuated parasites
may also provide valuable information.
Thus, the hepatic microenvironment from naïve and immune
animals is functionally distinct. While KCs from naïve mice
become deactivated upon contact with viable sporozoites and
eventually succumb to apoptosis (Steers et al., 2005; Klotz and
Frevert, 2008), activated KCs may phagocytose sporozoites, in
particular if immunization has generated high antibody levels.
As in other hepatic diseases (Nagy, 2003), the pro-inflammatory
microenvironment created by activated KCs could further
enhance the elimination of subsequent cohorts of sporozoites in a
local fashion. Depending on the number of attenuated sporozoites
used for immunization, challenge with viable sporozoites may
allow a few parasites to enter the liver. The finding that challenge
of immune mice with viable sporozoites resulted in a very low in
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FIGURE 2 | Model for Plasmodium antigen presentation in the liver.
(A) Sporozoites continuously release antigens such as CSP and TRAP from their
surface. On their way from the sinusoidal lumen into the liver parenchyma,
sporozoites glide along LSECs, traverse KCs, and migrate through several
hepatocytes before infecting a final one (red line). In naïve mice,
contact-mediated translocation of sporozoite antigens into the cytoplasm of
these liver cells may result in antigen presentation by LSECs, KCs, as well as
traversed and infected hepatocytes (red outline). (B) Sporozoite infection of
naïve mice should allow late-LS antigen expression exclusively on infected
hepatocytes, i.e., those cells in which the parasites develop (red outline).
(C) During repeated exposure to viable sporozoites or multiple rounds of
immunization with attenuated parasites, infected hepatocytes die after
completion of LS development, resulting in the release of debris and leftover
late-LS antigens into the environment. These late-LS antigens may then be
internalized by nearby APCs such as LSECs and KCs and cross-presented to
CD8 effector T cells monitoring the liver. (D) Of the various DC subsets that are
involved in inflammatory processes of the liver, the conventional CD8a+DCs are
required for the CD8 T cell-mediated elimination of Plasmodium LS. While their
exact location in the liver is unknown, Plasmodium infection likely attracts
immature cCD8a+DCs to the hepatic sinusoids, where they interact with KCs
and acquire sporozoite antigens. Extravasation into the space of Disse would
allow these DCs (blue) to communicate with CD8 effector T cells patrolling the
sinusoids. DCs may also internalize cellular and parasite debris released from
dead infected hepatocytes and subsequently cross-present these antigens to
CD8 effector T cells, either from within the space of Disse or after traveling to
the LNs that drain the liver.
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number of very small LS supports this idea (Cabrera et al., 2013).
In conclusion, the argument that sporozoites must avoid KC con-
tact to successfully infect the liver (Tavares et al., 2013) could
potentially be valid for the immune, but not for the naive host.
Whether KCs act as APCs to recall effector T cells in the Plas-
modium infected liver is unknown to date (reviewed in Frevert,
2004; Frevert et al., 2006, 2008b, 2014; Frevert and Nardin, 2008).
Owing to the unique immunological properties of the liver (Knolle
and Limmer, 2001; Sheth and Bankey, 2001; Bertolino et al.,
2002; Mackay, 2002; Racanelli and Rehermann, 2006; Crispe,
2009), KCs may respond to sporozoite contact with tolerance
rather than inflammation and immunity (Frevert et al., 2006). P.
berghei and P. yoelii sporozoites enter KCs actively by formation
of a vacuole and release CSP into the cytosol of these APCs in
vitro (Pradel and Frevert, 2001), suggesting that KCs can present
sporozoite surface antigens to both CD8 and CD4 effector T cells
(Figure 2). However, a number of reports support the notion that
KCs and other macrophages do not survive sporozoite contact
(Danforth et al., 1980; Smith and Alexander, 1986; Vanderberg
et al., 1990; Klotz and Frevert, 2008). In vitro studies revealed
that P. yoelii sporozoite CSP binds to the low density lipoprotein
receptor-related protein (LRP) and proteoglycans on the surface
of KCs, which leads to blockage of NADPH oxidase activation,
suppression of the respiratory burst, and generation of an anti-
inflammatory cytokine secretion profile (Usynin et al., 2007; Klotz
and Frevert, 2008). Thus, traversed KCsmay not be able to present
sporozoite antigens, because they lose APC function and succumb
to apoptosis (Klotz and Frevert, 2008). This notion is supported by
data from other experimental systems, in which KCs generate tol-
erance by inducing apoptosis in naïve CD8 T cells in the absence
of inflammation (Holz et al., 2012).
Another important finding was that sporozoites are able to
introduce CSP into mammalian cells without invading them
(Frevert et al., 1996; Hügel et al., 1996). CSP translocation across
the cell membrane into the cytosol requires neither the metabolic
nor the endocyticmachinery of the affected cell (Hügel et al., 1996;
Frevert et al., 1998; Pradel and Frevert, 2001) suggesting that it
involves a PEXEL motif (Singh et al., 2007). Once in the cytosol,
CSP binds to ribosomal RNA (Hügel et al., 1996), which interferes
with initiation step of protein synthesis (Frevert, 1999). In contrast
to the large number of enzymatically active cytotoxic plant, fungal,
and bacterial proteins, which require only a few molecules in
the cytosol to kill a cell (Stirpe et al., 1992; Barbieri et al., 1993;
Lacadena et al., 2007), CSP has a stoichiometric mode of action
(Frevert et al., 1998; Frevert, 1999). The effective concentration
of CSP leading to complete inhibition of translation likely varies
with the cell type, but complete blockage of the protein syn-
thesis machinery renders uninfected mammalian cells moribund
(Frevert et al., 1998). For example, large and metabolically highly
active cells such as hepatocytes, which are filled with a huge
amount of free and rough endoplasmic reticulum-associated ribo-
somes, are necessarily less sensitive to the stoichiometric ribotoxic
effect of CSP than the much smaller LSECs and KC with a much
less developed protein synthesis machinery. In agreement with
this notion, macrophages appeared to be particularly sensitive to
the ribotoxic action of CSP (Frevert et al., 1998). Nothing is known
about the possibility that sporozoite-mediated CSP translocation
induces apoptosis in LSECs and KCs. The resulting loss of these
APCs from the normally continuous sinusoidal cell layer would
expose the underlying parenchyma at the site of sporozoite gliding
and KC traversal, similar to the gaps generated by clodronate-
mediated KC removal from the sinusoidal cell layer (Baer et al.,
2007b), albeit to a much larger extent. As a consequence, effec-
tor T cells might gain direct access to traversed and/or infected
hepatocytes.
In conclusion, we are only beginning to understand the contri-
bution of KC to sporozoite infection of the liver and the effector
phase of immunity againstPlasmodiumLS. KCmay be deactivated
or even killed by contact with viable sporozoites or by the presence
of cytosolic CSP. Alternatively, KC may be activated by exposure
to opsonized sporozoites or immunization with attenuated para-
sites and turned into a source of pro-inflammatory cytokines. A
better understanding of these very different scenarios will reveal
whether KC (and LSEC) are able to process and present sporozoite
antigens for priming of naïve CD8 and CD4 T cells and for
induction of recall responses in effector memory T cells.
Dendritic Cells
Hepatic DCs are thought to play a major role in the cross-
presentation of hepatocyte-derived antigens (Bertolino and
Bowen, 2015). Under resting conditions, however, hepatic DCs
are immature. Due to their location in the periportal interstitium
and draining hepatic LNs, these professional APCs are not directly
accessible to CD8 effector T cells patrolling the hepatic sinusoids
(Figure 2). Pathological or inflammatory conditions trigger the
recruitment of blood-borneDCprecursors from the bonemarrow
to the liver sinusoids (Yoneyama and Ichida, 2005). In a murine
model of Propionibacterium acnes-induced granuloma model,
6 h were required for a significant number of myeloid DCs and
plasmacytoid DC precursors to accumulate in the liver of mice
with preexisting granulomata (Yoneyama and Ichida, 2005). After
antigen uptake, DCs enter the space of Disse, travel via the portal
Glisson’s capsule to the draining LNs for antigen presentation to
T cells followed by their activation (Sato et al., 1998). Thus, unlike
liver-resident APCs (LSECs and KCs), DCs must first travel to
the liver, which takes time. Other immune cells also arrive in the
liver with a considerable delay. For example, increased numbers
of Ly6Chi monocytes, which enter sites of inflammation and get
activated locally, were detectable 1 day after systemic infection
with Listeria monocytogenes (Shi et al., 2010). Further, continuous
intravital monitoring revealed that myelomonocytic cells begin
to arrive in and extravasate out of hepatic sinusoids roughly an
hour after surgical preparation of the liver for IVM (Frevert et al.,
2005). Since leukocyte accumulation occurred independently of
sporozoite infection, the recruitment of the cells is interpreted as
a response to injury.
With respect to malaria, the relative contribution of liver res-
ident versus recruited inflammatory DC is unknown to date
(Mauduit et al., 2012). Several studies have demonstrated a critical
role of CD8a+DCs in the activation of effector CD8 T cells
responding to an epitope of CSP.Mice that aremissing CD8a+DC
succumbed to infection in the aftermath of exposure to infectious
sporozoites (Layseca-Espinosa et al., 2013). In a murine model
of protective immunity induced by P. berghei RAS, CD8a+DC
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accumulated in the liver coincident with the exposure to Pb-RAS
sporozoites and induced CD8 T cells in vitro to produce IFN-
g, an activity that is IL-12 and MHC I dependent (Jobe et al.,
2009). Several possible scenarios have been proposed for the cel-
lular mechanisms by which CD8a+DCs contribute to protective
immunity (Jobe et al., 2009). CD8a+DCs might activate effector
CD8 T cells in the portal fields or in the draining hepatic LNs,
similar to plasmacytoid DCs, which normally do not remain in
the Disse spaces for extended periods of time (Yoneyama and
Ichida, 2005). Alternatively, CD8a+DCs might be recruited by
KCs located in the vicinity of infected hepatocytes and extravasate
into the spaces of Disse, similar to what has been observed for
myeloid DCs in the P. acnesmodel (Yoneyama and Ichida, 2005).
This would provide the advantage that Plasmodium-specific CTLs
could be activated directly in the sinusoid and that the resulting
release of cytokines and chemokines could kill LS at relatively
close range. Quantitative aspects are worth considering as well.
It could be argued that DC accumulation in the liver may not
be necessary for CD8 T cell activation, because in vitro studies
indicate that one CTL is sufficient to kill infected hepatocytes
or Plasmodium peptide-primed target cells (Bongfen et al., 2007;
Frevert et al., 2008a; Trimnell et al., 2009). However, sterile pro-
tection against Plasmodium infection requires extreme numbers
of CD8 effector T cells in the mouse model (Schmidt et al.,
2010) and the recruitment of large numbers of CD8 T cells to the
vicinity of LS (Cockburn et al., 2013). Together with the apparent
absence of direct CTL contact with the dying infected hepatocytes
(Cockburn et al., 2013), these data suggest that parasite elimi-
nation is relatively inefficient in vivo (see below). Therefore, the
recruitment of large numbers of DC to the liver may be required
for optimal antigen uptake to assure efficient presentation to and
activation of T cells in the draining LN. This unusual situation
where antigens are loaded onto APCs (in this case DCs) in the
liver for subsequent presentation in another organ, the draining
LN, may cause a large fraction of the malaria antigens to undergo
extensive proteolysis, resulting in a rather limited repertoire of
antigenic peptides to activate T cells. Further, if effector memory
CD8 T cells are activated in the draining LN they might return
to the liver with a considerable delay to kill LS and prevent the
erythrocytic phase of the infection.
In conclusion, a combination of DC recruitment to the liver,
subsequentDCmigration to the draining LN resulting in a limited
peptide repertoire, delayed T cell migration back to the liver, and
the impossibility to use direct contact-mediated cytotoxicity (see
below) may indeed render the CTL response quite ineffective in
conferring sterile protection to the host. Clearly, more work is
required to elucidate the relative contribution of recruited versus
resident hepatic DCs to the presentation of Plasmodium antigens
to T cells. Dynamic in vivo studies should be particularly suit-
able to shed light onto the local cellular interactions involved in
immunity.
Hepatocytes
After crossing the sinusoidal cell layer, sporozoites traverse several
hepatocytes before selecting a final cell for multiplication and dif-
ferentiation to thousands of merozoites (Mota et al., 2001; Frevert
et al., 2005). Asmentioned above, sporozoites continuously release
surface antigens while migrating (Stewart and Vanderberg, 1988,
1991, 1992; Spaccapelo et al., 1997). The first microscopic evi-
dence for the presence of sporozoite-released CSP in the cytosol
of infected hepatoma cells came from the Frevert lab (Hügel et al.,
1996; Frevert et al., 1998). Temporal analysis of infected HepG2
cells revealed that the amount of cytosolic CSP decreases with
increasing maturity of the intracellular LS. Further, because only
a few of the skin-deposited sporozoites get a chance to infect
hepatocytes, the amount of CSP available in the liver for either
direct presentation toCD8T cells or for cross-presentation involv-
ing non-parenchymal cells is limited (Chakravarty et al., 2007).
Nevertheless, as Plasmodium increases its chances for survival in
the liver by preventing the death of its host cell (van de Sand et al.,
2005; Sturm et al., 2006; Rennenberg et al., 2010; Graewe et al.,
2012; Kaushansky et al., 2013), antigen presentation toCD8T cells
might continue until merozoite replication and merosome release
are accomplished. Two groups proposed that Plasmodium LS
antigen presentation to CD8 effector T cells is restricted to hepa-
tocytes. First, by transplanting bonemarrow fromC57BL/6 donor
mice into lethally irradiated BALB/c recipient mice, Chakravarty
et al. (2007) created C57BL/6! BALB/c (H-2Kb!H-2Kd) bone
marrow chimera. Adoptive transfer of CS-TCRTgCD8T cells (H-
2Kd) into these chimera inhibited LS development, but not in the
reverse chimeric mice (Chakravarty et al., 2007). On the basis of
these observations, the authors suggested that CD8 effector T cells
must recognize CSP-derived antigen on hepatocytes to eliminate
Plasmodium LS from the liver. However, a role of radio-resistant
LSECs and stellate cells (SCs) cannot be excluded, because these
cells do not originate from the bone marrow (Bertolino and
Bowen, 2015). Further, sessile KCs are radiation-resistant (Klein
et al., 2007) and kinetic studies revealed that 85% of the recipient
KCs remain in the liver 2 months after standard bone marrow
transfer (BMT); even after 1 year, less than half of the original
KC population is replaced (Kennedy and Abkowitz, 1997; Seki
et al., 2009; Inokuchi et al., 2011). Therefore, to fully reconstitute
bone marrow derived cells in the liver, KCs must be depleted with
clodronate liposomes prior to irradiation and BMT (Van Rooijen
and Sanders, 1996). This strategy could be used to accurately
address the question of the role of KCs as APCs for Plasmodium-
specific effector T cells. In this scenario, KC may activate CD8
effector T cells to release inflammatory cytokines, such as IFN-
g, to eliminate Plasmodium parasites within infected hepatocytes.
In a separate study involving OT-I cells, it was observed that these
T cells significantly inhibited the parasite burden in C57BL/6mice
and bone marrow TAP / ! C57BL/6 chimeras infected with P.
berghei-OVA transgenic parasites, but not in C57BL/6! TAP / 
chimeras and TAP /  mice infected with the same parasites.
Kimura et al. (2013) concluded that infected hepatocytes process
and present the OVA epitope via the classical cytosolic MHC I
pathway.
Two decades ago, immunoelectron microscopy demonstrated
CSP in the cytosol of HepG2 cells harboring P. berghei sporo-
zoites (Hügel et al., 1996). In retrospect, we know now that
these sporozoites were traversing the hepatoma cells (Mota et al.,
2001; Frevert et al., 2005), because they were not enclosed in
a parasitophorous vacuole as required for productive infection
(Mota et al., 2001). Based on these in vitro data, it seems likely
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that both traversed and infected hepatocytes contain sporozoite
surface antigens in the liver (Figure 2). In vivo studies, on the other
hand, suggest that hepatocytes do not survive sporozoite traversal,
but undergo necrosis (Frevert et al., 2005). As a consequence,
sporozoite antigens associated with the remains of these disinte-
grating hepatocytes are likely phagocytosed and could be cross-
presented by liver APCs. In contrast, only infected hepatocytes
would contain early-late-LS, and eventually merozoite antigens
within the PV (Butler et al., 2011). Indeed, in vitro studies with
primary hepatocytes indicate that both traversed and infected cells
are able to process and present antigen to induce IFN-g secretion
in primed CD8 T cells (Bongfen et al., 2007). However, in vitro
exposure of primary hepatocytes to either WT or cell traversal-
deficient Pb-RAS revealed that only infected hepatocytes process
and present CSP via the proteasome pathway (Bongfen et al.,
2008), which led to the proposal that only infected hepatocytes
could induce their own elimination (Balam et al., 2012). Results
from in vivo experiments in a murine model revealed the capacity
of hepatocytes to induce protection by priming naïve T cells
and by presenting Plasmodium CSP to antigen-specific primed
CD8 T cells (Balam et al., 2012). As mice immunized with WT
and traversal-deficient sporozoites exhibited similar CD8 T cell
responses to CSP, the authors suggested that infected hepatocytes
play a dominant role in CD8 T cell priming in vivo. This inter-
pretation appears to contrast with the observation that hepatic
CD8a+DCs play a critical role in the activation of CD8 effector T
cells after immunizationwith Pb-RAS (Jobe et al., 2009). Although
it is entirely possible that different cells act as APCs during CD8
T cell priming in response to infection with attenuated sporo-
zoites, these APCs should express MHC-I:peptide complexes, co-
stimulatory signals and produce inflammatory cytokines (Zarling
et al., 2013). In addition, priming of CSP-specific responses may
also depend on the source of peripheral DCs (Chakravarty et al.,
2007; Cockburn et al., 2011). Together with the finding that
apoptotic infected hepatocytes can provide antigens to hepatic
DCs (Leiriao et al., 2005), and the notion that antigen presen-
tation by hepatocytes tends to have a tolerizing effect (Crispe
et al., 2006; Bertolino and Bowen, 2015), these data underscore
the need for more work to elucidate the cellular events within
the complex architecture of the intact liver with its large num-
ber of non-parenchymal cells (Racanelli and Rehermann, 2006;
Frevert and Nardin, 2008; Crispe, 2011), some of which exhibit
greater APC function than hepatocytes (Bertolino and Bowen,
2015).
Several different scenarios can be envisioned for cell-mediated
immunity directed against late-LS antigens in the naïve versus
the immunized host. For example, first-time infection of a naïve
host with WT sporozoites leads to expression of late-LS antigens
only in hepatocytes, the only liver cell type that supports para-
site growth and differentiation. Consequently, under experimen-
tal conditions that involve adoptive transfer of late-LS antigen-
specific CD8 CTLs into first-time infected recipient mice, these
CTLs should be able to recognize late-LS antigens exclusively on
infected hepatocytes (Figure 2). Although most merozoites are
successfully released into the blood, some parasite debris and LS
remnant bodies are left behind and inflammatory cells infiltrate
the exhausted former host cell (Baer et al., 2007a). If some of
these late-LS antigens are picked up by liver APC, then CTL
responses could be activated that would take effect against sub-
sequent generations of incoming parasites. For example, in mice
immunized with parasites under drug cover (Belnoue et al., 2004,
2008; Renia et al., 2013), which have experienced several complete
rounds of LS development, late-LS antigens left behind aftermero-
some release are likely internalized and cross-presented by hepatic
APCs, in particular LSECs andDCs (Figure 2). Similarly, repeated
exposure of humans to infected mosquito bites in endemic areas
may cause hepatic APCs to cross-present late-LS antigens. Thus,
under natural infection conditions, CTLs patrolling the sinu-
soids might recognize late-LS antigens on LSECs, DCs, and/or
KCs in addition to infected hepatocytes. Finally, hepatic APCs
may also present late-LS antigens after vaccination with late-
stage arrested GAS. We anticipate that advances in longitudinal
imaging with sensitive molecular tools will reveal the time of
parasite antigen persistence and the fate of GAS-infected host
cells.
In conclusion, a few parasites engage with a minute number
of hepatic APC in a highly local fashion within a huge organ.
Consequently, the fate of the LSECs and KCs that have been
touched or traversed by migrating sporozoites in vivo remains
unknown to date. We are confident that tools can be developed
and strategies designed to identify the few APCs at a time when
the parasites have already left, be it by imaging or otherwise,
for analysis of phenotypical changes in response to infection and
immunization.
Contact-Dependent Mechanisms against
Plasmodium Liver Stage Parasites
The mechanism by which effector cells eliminate Plasmodium
LS from the liver has been a matter of contention for decades
(Doolan and Hoffman, 2000). While Plasmodium-specific CTLs
can induce apoptosis in target cells by formation of an immuno-
logical synapse (Frevert et al., 2008a; Trimnell et al., 2009), fol-
lowed by contact-mediated cytotoxicity, the situation is more
complex in the liver, where infected hepatocytes are hidden
behind a layer of sinusoidal cells. Histological liver sections,
although suggestive (Rodrigues et al., 1992), are inadequate
to confirm CD8 T cell contact with infected hepatocytes and
granule-mediated cytotoxicity. Electron microscopy offers the
resolution to visualize CD8 T cell extravasation into the space
of Disse, formation of an immunological synapse, and chromatin
condensation indicating apoptotic target cell death (Frevert et al.,
2008a). However, comprehensive analysis of the small number of
LS developing in the large liver requires a more efficient method.
For example, dynamic in vivo imaging has been used successfully
to visualize subcellular details on the liver phase of Plasmod-
ium including sporozoite invasion, merozoite maturation, and
merosome release into the blood (Sturm et al., 2006; Baer et al.,
2007a). However, identification of the exact position of effector
T cells in the hepatic microenvironment by intravital imaging
requires simultaneous labeling of several crucial structural ele-
ments: the vascular lumen, the sinusoidal endothelium, the space
of Disse, hepatocytes, and the intracellular parasites. With the
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recent introduction of a novel imaging technique, intravital reflec-
tion recording, it is now possible tomonitor the behavior of T cells
in the hepatic microvasculature of non-fluorescent mice (Cabr-
era and Frevert, 2012). Combined with vascular tracers, cellular
or molecular markers, and fluorescent reporter mice, intravital
reflection recording represents a powerful technique to define
the exact location of effector T cells with respect to infected
hepatocytes and neighboring non-parenchymal cells, sinusoidal
endothelia and KCs.
Three recent studies aimed to identify themechanism by which
CD8 effector T cells kill Plasmodium LS in the liver. Using a
70–90% pure preparation of PyCSP TCR-Tg CD8 T cells specific
for the P. yoelii CSP epitope SYVPSAEQI, Cockburn et al. (2013)
showed that CD8 effector T cells cluster around Plasmodium LS in
the BALB/cmouse liver signaling viaGprotein-coupled receptors.
Both antigen-specific and antigen-unrelated OT-I cells exhibited
the same low velocity inside the cluster. Based on this report,
PyCSP TCR-Tg cells were proposed to recruit antigen-unrelated
OT-I cells to the site of P. yoelii LS development (Bayarsaikhan
et al., 2015) supporting the argument that all patrolling CD8 T
cells will slow down in an area where adhesion molecules are
upregulated, because there is no mechanism for recruitment to be
antigen specific, only engagement. Surprisingly, however, both the
parasite-specific T cells and the OT-I cells moved at slow speed
also outside the cluster (Cockburn et al., 2013). Other experi-
mental systems showed that when non-lymphoid tissue resident
memory CD8 T cells encounter cognate antigen, they recruit pre-
formed circulating memory CD8 T cells of the same specificity
to the site of infection (Schenkel et al., 2013). This specialized
feature of tissue resident CD8 T cells allows for an accumulation
of a large number of effector CD8 T cells prior to the protracted
process re-activation and arrival of antigen-specific cells induced
in the secondary lymphoid organs, e.g., the draining LN (Schenkel
et al., 2013). Another example suggesting that recruitment of CD8
T cells is strictly antigen-dependent comes from studies of tumor
killing by activated CTLs. The tumor antigen-specific CD8 T cells
migrate at high velocity (10mm/min) in the periphery of tumors
expressing cognate antigen, deeply infiltrate the tumors, and kill
tumors in a contact-dependent fashion (Boissonnas et al., 2007).
In contrast, the same CTLs do not infiltrate unrelated tumors
and neither arrest nor kill tumor cells that fail to present cognate
antigen.
One reason for the large size of the PyCSP TCR-Tg CD8 T cell
clusters (80 mm diameter) may be that the CD8 T cells received
MHCI:SYVPSAEQI signals from sporozoite-traversed cells in
addition to sporozoite-infected hepatocytes. This possibility is
difficult to evaluate, however, because the exact location of the
PyCSP TCR-Tg cells with respect to the sinusoidal walls is not
visible in that study (Cockburn et al., 2013). Whether these cells
were intra- or extravascular in this experimental setting based on
a single CSP-derived peptide remains to be shown. In addition,
whether large numbers of effector T cells also accumulate around
Plasmodium LS in natural infections or after immunization with
attenuated sporozoites, in particular in the large human liver,
also remains to be shown. Immunization with a viral prime
boost regimen against multiple epitopes in the P. falciparum
TRAP revealed that much lower levels of IFN-g producing CD8
T cells were required for protection of humans (Ewer et al.,
2013) compared to the high CD8 T cell frequencies necessary
for protection in mice (Schmidt et al., 2010). According to the
authors (Ewer et al., 2013), the significantly longer duration of P.
falciparum LS development, which lasts about 7 days compared to
the 2 days for rodent species, could be a plausible explanation for
this difference.
In agreement with the concealed location of hepatocytes in
the liver, CD8 T cells appear to use different mechanisms for
Plasmodium LS elimination in vitro and in vivo. Similar to classical
granule-mediated target cell killing, which is typically triggered
within seconds of CTL conjugation (Berke, 1995; Keefe et al.,
2005; Pipkin and Lieberman, 2007), P. yoelii specific CD8 T cells
rapidly induce apoptosis in infected hepatocytes in vitro and kill
the parasites efficiently using a contact- and perforin-dependent,
but IFN-g independent mechanism (Trimnell et al., 2009). In
contrast, P. yoelii LS killing in vivo is a protracted process that is
contact-independent and requiremultipleCD8T cells per parasite
(Cockburn et al., 2013). Together with the finding that CD8 T
cells from P. yoelii GAS-immunized mice rely partly on IFN-g
for protection (Trimnell et al., 2009), these intravital observations
suggest that cytokines are responsible for the PyCSP TCR-Tg cell-
mediated LS killing (Cockburn et al., 2013). Compared to clas-
sical granule-mediated cytotoxicity, cytokine-mediated effector
mechanisms operate slower and, depending on the local cytokine
concentration,may range frommere growth stagnation to parasite
death.
Another study showed that OT-I CD8 T cells accumulate in
very large numbers around mature LS in the livers of naïve
C57BL/6 mice 40–48 h after infection with P. berghei-gfpOVA
(Kimura et al., 2013). Whether or not these T cell clusters formed
around all LS was not reported, but as LS development is highly
asynchronous, some LS had likely matured and released mero-
somes, which is typically followed by infiltration of the remains
of the dead hepatocytes with inflammatory cells (Khan and Van-
derberg, 1991a; Baer et al., 2007a). Alternatively, the clusters
were formed by T cells specific for late-stage antigens that appear
in the hepatocyte cytoplasm, in this case OVA (Bayarsaikhan
et al., 2015). Depending on the host-parasite combination, mice
can also mount inflammatory responses prior to LS maturation.
For example, P. berghei sporozoites are 2000-fold less infectious
to BALB/c mice than to C57BL/6 mice (Scheller et al., 1994).
On the other hand, P. yoelii is 50–100 times more infectious to
C57BL/6 mice than P. berghei (Briones et al., 1996). As a result,
the P. berghei parasite biomass in the C57BL/6 mouse liver is
significantly lower than that of P. yoelii suggesting that P. berghei
induces an inflammatory response not only in BALB/c mice, but
also in C57BL/6 mice. Granuloma formation in naïve P. berghei-
infected mouse livers starts at 24 h after infection and is therefore
clearly independent of adaptive immune mechanisms. The find-
ing thatP. yoelii LS develop basically undetected in themouse until
merosome release is accomplished (Khan and Vanderberg, 1991b;
Liehl et al., 2014) supports this notion (see caveat below). Taken
together, CD8 effector T cells appear to participate in granu-
loma formation aroundmoribund P. berghei-infected hepatocytes
(Kimura et al., 2013). The alternative hypothesis, namely that
CD8 T cells cluster around healthy LS that successfully develop
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in the liver of naïve mice or humans, requires experimental
confirmation.
A third study presents novel imaging techniques that proved
essential for visualization of the exact location of CD8 effector
memory T cells in the Plasmodium-infected liver (Cabrera and
Frevert, 2012). Intravital reflection recording revealed that immu-
nization of BALB/cmice with radiation-attenuated P. yoelii sporo-
zoites (Py-RAS), early-stage genetically attenuated (Py-uis4 / ),
or late-stage genetically attenuated (Py-fabb/f / ) parasites sig-
nificantly increased the velocity of CD8 T cells patrolling the
hepatic microvasculature compared to naïve mice (Cabrera et al.,
2013). After adoptive transfer, CD8 T cells from these immu-
nized donormice unexpectedly remained immobile in the hepatic
microvasculature for at least 3 days, whether or not the recipient
mice were infected (Cabrera et al., 2013). The same low velocity
was observed after transfer of TCR-tg CD8 T cells specific for the
P. yoelii CSP280 288 epitope (Butler et al., 2010; Schmidt et al.,
2011). Instead of migrating with a leading edge and a trailing
uropod as in immunized mice, the transferred CD8 T cells were
rounded (Cabrera et al., 2013) andmet the definition of local con-
finement (Friedl andWeigelin, 2008). In fact, an 28% pure PyCSP
TCR-tg CD8 effector memory T cells exhibited a similarly low
average velocity after adoptive transfer as the 70–90% pure PyCSP
TCR-Tg CD8 effector T cells mentioned above (Cockburn et al.,
2013). Although recipient mice were infected with one million
sporozoites, a parasite density that should have facilitated CTL
encounters with LS, none of the transferred CD8 T cells, whether
of hepatic or splenic origin, approached or made contact with
infected hepatocytes under any of the experimental conditions
used (Cabrera et al., 2013). Because neither immunized donor
mice nor infected recipientmice provided any evidence for CD8 T
cell extravasation into the space of Disse, the CD8 effector mem-
ory T cells from the immunized mice likely eliminated infected
hepatocytes via release of soluble mediators, cytokines and/or
chemokines (Frevert and Nacer, 2013; Miller et al., 2014). The
finding that adoptive transfer of two million purified CD8 T cells
from Pb-uis3 /  immunized mice conferred sterile protection
to challenge with 50,000 viable sporozoites supports this notion
(Mueller et al., 2007).
In conclusion, while conducted under very different conditions
in terms of Plasmodium species, CD8 T cell specificity, and time of
imaging, common denominators that emerge from these studies
are (1) the low velocity of adoptively transferred CD8 T cells,
whether antigen-specific or not and whether in proximity to the
parasites or not, in the liver of recipient mice, (2) the lack of
direct CD8 T cell contact with infected hepatocytes, and (3) the
considerably slower LS killing in vivo compared to hepatocyte
monocultures, where CTLs have direct access infected hepato-
cytes.
Adoptive Transfer-Associated Phenotypical
CD8 T Cell Changes in Other Systems
Muchof our current understanding of T cell functions comes from
experiments using adoptive transfers of either enriched T cell sub-
sets displaying a certain phenotype or T cells bearing a TCR-Tg for
a given specificity. Recent advances in the use of intravital imaging
have provided us with a much clearer understanding of T cell
functions vis-à-vis the patterns of migratory behavior within the
various lymphoid and non-lymphoid organs. The microarchitec-
ture of each organ and the expression ofMHC:peptide complexes,
chemokines, adhesion molecules and cytokines provide signaling
pathways that prompt specific movement and velocity patterns, as
well as changes in T cell function. Collectively, these observations
suggest a certain plasticity of most T cells is needed mainly to
prevent tissue pathology, while simultaneously enhancing T cell
effector function against invading pathogens. For example, liver
CD8 T cells specific for HBV modulate their IFN-g production
and cytolytic function in an oscillatory and sequential fashion,
which culminates in effective reduction of viral load (Isogawa
et al., 2005). Th17 cells convert to IFN-g producing Th1-like cells
after adoptive transfer into NOD/SCID recipient mice (Bending
et al., 2009; Martin-Orozco et al., 2009). Further, adoptively trans-
ferred resting memory CD8 T cells acquire an effector phenotype
upon entry into non-lymphoid tissues as indicated by induction
of lytic activity and granzyme B expression (Marzo et al., 2007).
Some of these observed changesmay simply reflect a programmed
T cell differentiation, e.g., from resting memory to effector cells,
upon reinfection. Changes in the profiles of cytokine production
or lytic function may also indicate that anatomical location plays
a role in local T cell differentiation.
Cytokine-Mediated Effector Mechanisms
against Plasmodium Liver Stages
Nonspecific responses tomicroenvironmental changes could pro-
vide an alternative explanation for the finding that antibody-
mediated blockage of IFN-g abrogated protection against Plas-
modium LS within 2 days (Schofield et al., 1987b; Rodrigues et al.,
1991; Weiss et al., 1992), but neither 8 days after CD8 T cell
transfer (Chakravarty et al., 2008) nor in immunized mice in
the absence of adoptive transfer (Doolan and Hoffman, 2000).
Whatever the cause of the immobility of adoptively transferred
CD8 effector T cells, this phenomenon is useful to demonstrate
that direct contact is not necessary for CTL-mediated protection
against Plasmodium LS. Blockage of IFN-g within 2 days after
transfer abrogates protection (Schofield et al., 1987b; Rodrigues
et al., 1991; Weiss et al., 1992), a result that supports the concept
that soluble factors are obligatory for protection when CTLs are
unable to approach infected hepatocytes. A role of cytokines, in
particular IFN-g and TNF-a, in parasite killing is clearly docu-
mented, both in vivo and in vitro (Ferreira et al., 1986; Mellouk
et al., 1987, 1991; Schofield et al., 1987a; Rodrigues et al., 1991;
Weiss et al., 1992; Seguin et al., 1994; Renggli et al., 1997; Doolan
and Hoffman, 2000; Jobe et al., 2007; Mueller et al., 2007; Butler
et al., 2010). For example, C57BL/6mice deficient in both perforin
and the CD95/CD95L pathway were protected after immuniza-
tion with Pb-RAS suggesting that parasite-specific CD8 effector
T cell-derived cytokines activate mechanisms responsible for the
elimination of the intracellular LS (Renggli et al., 1997).
IFN-g is now considered the central mediator of protection
against LS (McCall and Sauerwein, 2010). However, the finding
that (1) blockage of IFN-g does not abolish protection in actively
immunized mice (Doolan and Hoffman, 2000), (2) CD8 T cells
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from IFN-g deficient mice protect mice challenge 8 days after
transfer (Chakravarty et al., 2008), when the CTLs have likely
regained motility, and (3) CD8 T cells protect IFN-g KO mice
against infection (Butler et al., 2010) all suggest that IFN-g is not
the only soluble factor involved. CD8 T cells monitor hepatocytes
with small cytoplasmic projections that reach into the space of
Disse (Warren et al., 2006), but they appear not to extravasate
into the liver tissue or form immunological synapses with hep-
atocytes in vivo (Crispe, 2011). Interestingly, while perforin-
dependent cytotoxicity plays an important role in the clearance
of virus infections from extrahepatic organs, this mechanism was
not involved in the elimination of hepatocytes infected with a
non-cytopathic adenovirus from the liver (Kafrouni et al., 2001).
Because hepatic CD8 T cells exhibited similar IFN-g and TNF
responses and were able to kill virus-infected cells in vitro, this
finding was interpreted as a relative resistance of hepatocytes
to perforin-mediated cytotoxicity (Kafrouni et al., 2001). Alter-
natively, however, CD8 T cells may be unable to use contact-
dependent cytotoxicity because they cannot exit the hepatic sinu-
soid (Cabrera et al., 2013; Frevert and Nacer, 2013). Of note,
CTLs can form two different types of immunological synapses
(1) lytic synapses, used for target cell killing and (2) stimula-
tory synapses with APCs to induce cytokine secretion (Faroudi
et al., 2003; Depoil et al., 2005; Wiedemann et al., 2006). It seems
therefore possible that CTLs specific for Plasmodium sporozoite
proteins recognize—from within the sinusoidal lumen—antigens
at the site of parasite entry into the parenchyma, form stimulatory
synapses with sinusoidal APC, in particular KCs, secrete IFN-
g in a multidirectional fashion (Kupfer et al., 1991; Huse et al.,
2006; Sanderson et al., 2012), and trigger the secretion of addi-
tional cytokines such as IL-6 and IL-12 that then contribute to
LS killing (Nüssler et al., 1991; Pied et al., 1991, 1992; Vreden
et al., 1992; Belnoue et al., 2004). Synapse formation with sinu-
soidal APCs could involve cytotoxic granule proteins (Doolan
and Hoffman, 2000; Butler et al., 2010), which might explain
the requirement for perforin in protection of vaccinated humans
(Seder et al., 2013) and mice (Butler et al., 2010). This scenario
could also pertain to CTLs that recognize late-LS antigens on
cross-presenting APCs.
How can CTL-derived cytokines reach infected hepatocytes
(Figure 1)? Considering the high sinusoid-to-lymph filtration
rate (Greenway and Lautt, 1970; Laine et al., 1979; Henriksen
et al., 1984), the enhanced pressure gradients created by leukocytes
moving through the sinusoidal lumen (Wisse et al., 1983), and
the highly anastomosed sinusoidal microvasculature, CD8 T cells
could conceivably exploit both the anterograde blood flow and the
retrograde lymph flow to take control of a large portion of the
liver lobule—without extravasation and granule-mediated cyto-
toxicity (Frevert and Nacer, 2013). This hypothesis is supported
by the finding that intravenous IFN-g inoculation reduced the
P. berghei liver burden independently of the sporozoite challenge
dose (Ferreira et al., 1986). Further, CD8 T cells protect against
various viral liver infections and in vivo data indicate that virus
replication is blocked without CD8 T cell extravasation and in
the absence of hepatocyte death (Guidotti et al., 1999; Kafrouni
et al., 2001; Guidotti, 2002; Crispe, 2011). Consistent with the
notion that CTL-derived cytokines traverse the sieve plates of the
sinusoidal endothelia and disseminate via the lymphatic conduits
of the liver, adoptively transferred-specific CTLs acted against
infected hepatocytes, but had no effect on not infected renal
tubule or choroid plexus epithelia (Ando et al., 1994a), both of
which are shielded from the bloodstream by a continuous layer of
non-fenestrated endothelia.
While the crucial role of perforin expressing CD8 T cells in
protection againstPlasmodium LS is nowwell documented (Reng-
gli et al., 1997; Doolan and Hoffman, 2000; Trimnell et al., 2009;
Butler et al., 2010), the exact mechanism by which this cytotoxic
granule protein contributes to the elimination of infected hepa-
tocytes in vivo is unclear. CTLs typically release perforin into an
immunological synapse (Lieberman, 2003; Pipkin and Lieberman,
2007; Lopez et al., 2013). Unlike Fas/FasL-mediated cytotoxicity,
which requires only a few molecules on the target cell and which
could therefore potentially be accomplished via small cytoplasmic
projections such as TEHLI (Warren et al., 2006), immunological
synapse formation involves a much larger area of contact between
CTL and target cell (Dustin, 2005; Pipkin and Lieberman, 2007).
For this reason, establishment of synapse with the basolateral
hepatocyte membrane likely requires extravasation of the CTL.
However, CTLs conjugating with hepatocytes from within the
space of Disse have not been documented to date, neither in
malaria nor in other liver infections. While CTLs specific for
the were initially thought to exert a direct cytopathic effect on
infected hepatocytes in vivo (Ando et al., 1994b), the use of a
transgenic mouse model of hepatitis B infection revealed that
adoptively transferred virus-specific CTLs abolish gene expres-
sion and replication of the virus in the liver in the absence of
hepatocyte death (Guidotti and Chisari, 1996; Guidotti et al.,
1999; Kafrouni et al., 2001; Wuensch et al., 2006; Giannandrea
et al., 2009). Thus, rather than reflecting secretion of cytotoxic
molecules and induction of apoptosis, which requires immuno-
logical synapse formation with the target cell, the requirement
of perforin expression for protection may indicate CD8 T cell
maturation in the liver. This model would also link perforin
expression to IFN-g secretion. It is now established that CTLs
eliminate the virus by secretion of IFN-g and TNF-a and that
this cytokine-mediated, non-cytopathic mechanism represents a
survival strategy of the host to control massive viral infections of
vital organs such as the liver (Guidotti, 2002). Clearly, widespread
takeover of the hepatocyte machinery by a hepatotropic virus
differs from the very focal intracellular development of a large
protozoan parasite such as Plasmodium. However, all available
evidence suggests that both infectious agents can be eliminated via
cytokines, i.e., in the absence of CTL extravasation and immuno-
logical synapse formation with antigen-presenting hepatocytes.
Taken together, CTLs appear to be more likely to engage in stim-
ulatory immunological synapse formation with sinusoidal APCs
rather than establishing lytic synapses with infected hepatocytes.
However, this aspect of effector CD8 T cell activity will need to
be investigated further. Confocal or multi-photon microscopy,
combined with cellular and molecular tools for intravital imag-
ing of the hepatic microvasculature (Cabrera and Frevert, 2012),
can provide the necessary spatio-temporal resolution to elucidate
which liver cell types interact with which Plasmodium antigen-
specific CD8 T cells and whether discrete epitopes of the still
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unknown liver-stage specific antigens require specific hepatocyte
and/or APC contacts.
Much is known about the cytotoxic mechanisms associated
with immunological synapse formation in vitro (Russell and Ley,
2002; Catalfamo and Henkart, 2003; Lieberman, 2003; Trambas
and Griffiths, 2003). For example, upon in vitro conjugation of
human-specific CD8 T cells with cognate target cells, perforin
rapidly accumulates at the immunological synapse where it pro-
motes cytotoxicity (Makedonas et al., 2009). Although cellular
cytotoxicity against congenic hepatocytes has been studied exten-
sively in various virus hepatitis models (Guidotti et al., 1999;
Kafrouni et al., 2001; Wuensch et al., 2006; Giannandrea et al.,
2009), CTL conjugation with target hepatocytes in the intact liver
has not been documented to our knowledge, neither ultrastruc-
turally nor with the combined use of modern fluorescent tools
and state-of-the-art imaging techniques. Unlike the continuous
endothelium of other organs, which prevents ready access of sol-
uble mediators to the parenchyma, one of the essential functions
of the fenestrated sinusoidal endothelium of the liver is to allow
unrestricted passage of soluble and small corpuscular substances
to hepatocytes for detoxification and a plethora of anabolic and
catabolic processes. Further, the liver is unique in that every
hepatocyte is in direct contact with sinusoidal endothelia thus
allowing screening by patrolling immune cells and exposure to
their secreted cytokines. This is in stark contrast to other organs,
which require immune cell infiltration for elimination of infected,
malignant, or otherwise abnormal target cells. This applies in
particular to organs with a tight blood barrier such as brain or
testes or tissues comprised of a dense parenchymawith a relatively
low degree of vascularization such as joint or cartilage.
In conclusion, it appears that CD8 effector T cells recognize the
site of sporozoite entry into the liver, either by detecting antigen
presented on hepatic local APC or by screening hepatocytes via
TEHLI. Being unable to extravasate and kill via classical granule-
mediated cytotoxicity, CTLs appear to eliminate Plasmodium LS
via secretion of cytokines, in particular IFN-g.
Cytokine-Mediated Control of Parasite
Growth
Cytokines alone can clearly confer protection against Plasmodium
LS, further supporting the notion that CTL-mediated cytotoxi-
city does not require contact with infected hepatocytes. In vitro
studies document that P. yoelii and P. falciparum infected hepa-
tocytes can be eliminated by direct exposure to IFN-g (Ferreira
et al., 1986; Mellouk et al., 1991, 1994) and intravenous IFN-g
inoculation reduced liver burden in a P. berghei model (Ferreira
et al., 1986). Antibodies against CD8 T cells or IFN-g abro-
gated protection (Ferreira et al., 1986), suggesting that CD8 T
cells either secrete sufficient IFN-g or produce other cytokines
that elicit IFN-g secretion from other cellular sources (Schofield
et al., 1987b). Clearly, IFN-g mediated protection is dependent
on iNOS-mediated production in infected hepatocytes (Mellouk
et al., 1991, 1994; Nussler et al., 1993; Seguin et al., 1994; Klotz
et al., 1995). However, despite the essential role of IFN-g in iNOS
upregulation in infected hepatocytes (Nussler et al., 1993; Seguin
et al., 1994; Klotz et al., 1995), the exact mode of operation of
this cytokine in vivo is not known (Doolan and Hoffman, 2000;
Overstreet et al., 2008; Butler et al., 2010). Interestingly, IFN-g
induced iNOS activation was shown to regulate the replication of
various obligatory intracellular microorganisms including Toxo-
plasma (Pfefferkorn, 1984, 1986; Pfefferkorn et al., 1986; Takacs
et al., 2012), Trypanosoma cruzi (Silva et al., 2003), Leishmania
(Bogdan et al., 2000), Mycobacterium (Herbst et al., 2011), and
Chlamydia (Zhang et al., 2012). An IFN-g based regulatorymech-
anism could explain why challenge of immunizedmice results not
only in a smaller number of Plasmodium LS (as expected for a
direct killing mechanism), but also in a reduced LS size (Cabrera
et al., 2013). In agreement with this finding, the effect of IFN-g
induced iNOS activation may range from aminor reduction in LS
growth to complete cure of the host cell depending on the local
CD8 T cell density, the level of IFN-g secretion, the position of
the T cells and the LS relative to the liver lobule, and the distance
between them.
Thus, it appears that CTLs exert an IFN-g mediated growth-
regulatory effect on Plasmodium LS rather than acting in a par-
asitocidal fashion. To be efficient, this mechanism requires an
organ with sinusoidal endothelia, a large trans-endothelial lymph
filtration rate, and a highmicrovascular density that exposes every
parenchymal cell to CTL-derived cytokines—properties uniquely
combined in the liver. Considering that a similar mechanism
of cellular immunity has been proposed to operate against viral
infections of the liver (Guidotti, 2002; Guidotti and Iannacone,
2013), IFN-g induced iNOS activation in hepatocytes (Chen
et al., 2003) may have evolved as an efficient strategy to control
hepatotropic microbes while promoting hepatocyte survival and
preserving the function of this essential organ.
Contribution of Cellular Effector
Mechanisms to Protection of Naïve Versus
Immune Hosts
Plasmodium has developed multiple parallel strategies to evade
detection in the liver: the choice of a tolerogenic environment for
its initial round of replication, the limited infection of a minute
number of hepatocytes in the huge liver, and the change of protein
expression from sporozoite to late-LS antigens. For these reasons,
it has been suggested that finding and killing all LS during the brief
period of LS development represents the predominant challenge
the CD8 T cell response is facing (Bertolino and Bowen, 2015).
Indeed, this reasoning clearly applies to the most severe malaria
cases, namely to first infections of naïve hosts that result in a fatal
outcome after only one round of LS development. In these cases,
effective CTL-mediated interruption of LS development would
prevent the clinically symptomatic blood infection in young P.
falciparum-infected children and also allow susceptible mice to
survive experimental infection with large numbers of lethal P.
yoelii XL or P. berghei ANKA sporozoites.
After repeated infections, for example with non-lethal parasite
species/strains or with sub-lethal inoculation doses, protection
increasingly relies on the humoral arm of immunity. Challenge
of immunized mice by mosquito bite likely allows antibodies to
immobilize most sporozoites in the skin (Vanderberg and Frevert,
2004). Should a few parasites manage to escape from the skin,
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they are likely opsonized in the bloodstream and phagocytosed by
KCs. In contrast to liver infection of naïve mice, which is very fast
and highly efficient (Shin et al., 1982; Conteh et al., 2010), studies
with mice that had been vaccinated with P. yoelii RAS or GAS
showed that the majority of intravenously inoculated sporozoites
are unable to enter the liver (Cabrera et al., 2013). Thus, LS devel-
opment in the immune host is impeded and extremely scarce,
which drastically reduces the probability of parasite recognition by
Plasmodium-specific CD8 T cells, in particular in the large human
liver. These considerations emphasize the crucial role of antibod-
ies in protection of the previously exposed host against recurring
sporozoite infections (Vanderberg et al., 2007; Vanderberg, 2014).
Contribution of Innate Immune Responses
to Protection against Plasmodium LS
Recent studies demonstrate a significant impact of the innate
immune response on the survival of Plasmodium in the murine
liver. Both P. berghei and P. yoelii infected hepatocytes were
shown to sense Plasmodium LS and induce a type I IFN response
that is propagated by hepatocytes in an interferon-a/b receptor
dependent fashion and reduces the parasite burden in the liver
(Liehl et al., 2014; Miller et al., 2014). In the P. yoelii model,
primary infection with a late-stage GAP increased the number
of IFN-g secreting CD1d-restricted NKT cells in the liver thus
implicating IFN-g as a crucial innate factor in controlling sec-
ondary infection with WT XNL parasites (Miller et al., 2014).
Although lymphocytes were required for the innate suppression
of secondary liver infections, CD8 T cells, CD4 T cells, and NK
cells, the latter of which constituted the largest subset of IFN-g
secreting cells, appeared to be dispensable as effector cells. Type I
IFN signaling was responsible for the recruitment of both CD8 T
cells and CD49b+CD3+ NKT cells to the liver, but only NKT cells
reduced the LS burden significantly (Miller et al., 2014), which is
in line with earlier work (Gonzalez-Aseguinolaza et al., 2000).
Certain differences between the two murine models are note-
worthy. For example, the innate immune response to P. berghei
infection involved the cytosolic pattern recognition receptor
MDA5, the adaptor molecule for cytosolic RNA sensors, MAVS,
suggesting parasite RNA sensing, and the transcription factors
IRF3 and IRF7 (Liehl et al., 2014). In the P. yoeliimodel, IRF3, but
not IRF7, was crucial for the induction of the type I IFN response
and neither MDA5 nor MAVS contributed to a functional innate
response against secondary infection (Miller et al., 2014). Fur-
ther, P. berghei infection activated a considerably stronger innate
immune response compared to P. yoelii, and interferon-stimulated
gene expression was upregulated at 36 h after infection with WT
P. berghei, but only at 42 h after infection with WT P. yoelii
(Liehl et al., 2014). In agreement with earlier histological work
(Khan and Vanderberg, 1991b), immune cell infiltration occurred
midway through completion of LS development for P. berghei,
but only at the time of merosome formation for P. yoelii (Miller
et al., 2014). Finally, IFN-g signaling pathways were upregu-
lated as early as 24 h after infection with late-stage arrested P.
yoelii parasites (Miller et al., 2014), while early stage-arrested P.
berghei parasites (GAS or RAS) failed to induce such a response
(Liehl et al., 2014).
Thus, many questions remain. For example, is the intense
inflammation and early granuloma formation associated with P.
berghei infection of the murine liver the cause or the consequence
of the type I IFN response? Is parasite death required for RNA
sensing and initiation of the innate response? Can LS sensing
be improved by parasite attenuation? Addressing these issues
may provide crucial clues as to which events in the life cycle
reveal the presence of the parasite to the host. Perhaps most
relevant for malaria endemic areas: does the human host indeed
sense intracellular LS if infected with a well adapted Plasmodium
species?
Outlook and Future Directions
We hope to have highlighted the vast number of open questions
associated with the local cellular events leading to protection
against Plasmodium LS. While much progress has been made
on the biology and nutritional requirements of Plasmodium LS
(Luder et al., 2009; Vaughan et al., 2009; Rankin et al., 2010;
Labaied et al., 2011; Deschermeier et al., 2012; Graewe et al.,
2012; Itoe et al., 2014), the liver is still a black box in terms of
effector mechanisms mediating the detection and elimination of
infected hepatocytes. Recent live attenuated malaria vaccination
trials in humans and non-human primates as well as work in
mice clearly demonstrate the requirement for protection of large
quantities of IFN-g producing CD8, CD4, and gd T cells as well
as IFN-g secreting NK and NKT cells in the liver (Epstein et al.,
2011; Teirlinck et al., 2011; Seder et al., 2013). Neither location
nor behavior in the liver of any of these cells nor their exact
modes of action during adaptive and innate immunity has been
determined, however. Elucidation of the protective cell-mediated
mechanisms elicited by attenuated sporozoite vaccines will aid in
the development of a cheap, safe, and easy-to-administer synthetic
vaccine that matches this gold standard. As hundreds of millions
of people living in endemic areas are in desperate need for pro-
tection against malaria, future vaccination protocols should be
selected based on their capacity to boost the number of CD8 T
cells. Indeed, a multi-epitope malaria vaccine that significantly
increases the magnitude of T cell induction has already been
developed (Ewer et al., 2013). This so-called ME-TRAP vaccine
contains full-length Plasmodium falciparum TRAP fused to ME,
a string of 20 malarial T and B cell epitopes (McConkey et al.,
2003).
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